Loading...
Zydus Lifesciences Limited — Iron Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #1 for Iron · $21.6M export value · DGFT Verified
Zydus Lifesciences Limited is the #1 Indian exporter of Iron with $21.6M in export value and 432 verified shipments. Zydus Lifesciences Limited holds a 4.4% market share in Iron exports across 4 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $13.1M | 420 | 97.8% |
| SRI LANKA | $293.5K | 8 | 2.2% |
| BELGIUM | $108 | 1 | 0.0% |
| SLOVENIA | $31 | 3 | 0.0% |
Zydus Lifesciences Limited exports Iron to 4 countries. The largest destination is UNITED STATES accounting for 97.8% of Zydus Lifesciences Limited's Iron shipments, followed by SRI LANKA (2.2%) and BELGIUM (0.0%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $13.0M | 413 |
| HEMAS PHARMACEUTICALS (PVT) LTD | SRI LANKA | $293.5K | 8 |
| EVERSANA LIFE SCIENCE SERVICES, | UNITED STATES | $66.4K | 6 |
| EVERSANA LIFE SCIENCE SERVICES. | UNITED STATES | $22.6K | 1 |
| GEA PHARMA SOLIDS CENTER (GPSC) | BELGIUM | $108 | 1 |
India exported $148.4M worth of Iron through 14,943 shipments from 943 suppliers to 174 countries, serving 2,171 buyers globally. Zydus Lifesciences Limited contributes $21.6M to this total, accounting for 4.4% of India's Iron exports. Zydus Lifesciences Limited ships Iron to 4 countries through 6 buyers.
Zydus Lifesciences Limited's average Iron shipment value is $50.0K per consignment, based on 432 shipments totaling $21.6M. The largest destination is UNITED STATES (97.8% of Zydus Lifesciences Limited's Iron exports).
Zydus Lifesciences Limited ranks #1 among 943 Indian Iron exporters with a 4.4% market share. The top 3 exporters are UNICHEM LABORATORIES LIMITED ($32.2M), ZYDUS LIFESCIENCES LIMITED ($21.6M), AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($18.8M). Zydus Lifesciences Limited processed 432 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SPIRONOLACTONE TABLETS 25MG (SPIRONOLACT | $494.7K | 10 |
| SPIRONOLACTONE TABLETS 50MG (SPIRONOLACT | $251.3K | 6 |
| BUSPIRONE HCL TABLETS USP 15 MG - 1 X 500 OTHER DTLS AS PER INVOICENOS | $244.7K | 6 |
| SPIRONOLACTONE TABLETS 100MG (SPIRONOLAC | $221.6K | 5 |
| PHARMA MEDICINE FOR HUMAN USE-BUSPIRONE | $219.6K | 6 |
| FERUP SG CAPS (IRON, MINERALS & VITAMINSOFT GELATIN CAPSULES) 4X30 SHIPMENT UNDER LUT No.AD0503240056877 Dated 18.03.20 | $156.3K | 5 |
| BUSPIRONE HCL TABLETS USP 30 MG - 1 X 60 | $155.9K | 4 |
| BUSPIRONE HCL TABLETS USP 15 MG - 1 X 50 | $150.0K | 3 |
What Zydus Lifesciences Limited must comply with to export Iron to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | UNICHEM LABORATORIES LIMITED | $32.2M | 644 | 3 | $50.0K |
| 1 | ZYDUS LIFESCIENCES LIMITED ★ | $21.6M | 432 | 4 | $50.0K |
| 3 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $18.8M | 375 | 1 | $50.0K |
| 4 | INTAS PHARMACEUTICALS LIMITED | $16.5M | 1,319 | 18 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,808 | 12.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,771 | 11.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,230 | 8.2% |
| DELHI AIR | 1,025 | 6.9% |
| JNPT/ NHAVA SHEVA SEA | 707 | 4.7% |
| MUNDRA SEA | 632 | 4.2% |
| JNPT | 627 | 4.2% |
Zydus Lifesciences Limited also exports these vitamins & supplements products. Each links to the detailed product page.
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Iron, top products include Losartan, Carvedilol, Mesalamine, Omeprazole, Potassium. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Iron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Iron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
| SENSUM D O O | SLOVENIA | $31 | 3 |
Zydus Lifesciences Limited supplies Iron to 6 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by HEMAS PHARMACEUTICALS (PVT) LTD (SRI LANKA) and EVERSANA LIFE SCIENCE SERVICES, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| SPIRONOLACTONE TABLETS 25 MG - 1 X 1000,B.NO Z306352 TO Z306356 MFG.DT. 12/2023EXP.DT. 11/2025NOS |
| $150.0K |
| 3 |
| SPIRONOLACTONE TABLETS 100MG 1X500 BNO;Z306342,Z306343,Z306344,Z306345(10688 PACKS)NOS | $150.0K | 3 |
Zydus Lifesciences Limited exports 216 distinct Iron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SPIRONOLACTONE TABLETS 25MG (SPIRONOLACT with 10 shipments worth $494.7K.
| $12.5K |
Zydus Lifesciences Limited ranks #1 among 943 Indian Iron exporters. Average shipment value of $50.0K compared to the market average of $157.4K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and AMNEAL PHARMACEUTICALS PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 174+ countries, 2,171+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Iron. For current shipment-level data, contact TransData Nexus.